Sentence examples for assay at a from inspiring English sources

In addition, they show little potential for multiplexing capabilities since they can conduct only one assay at a time.

A decrease of luciferase activity in the ER Calux assay at a triclocarban concentration of 125 μg/L and higher was observed.

For the early phase 1/2 study, clinical samples from a total of 72 ALL patients were tested for binding antibodies in the ADA assay at a scheduled visit.

Giannitsis and associates demonstrated that, compared with the 4th generation cTnT, the admission hs-cTnT assay (at a cutoff of 99th percentile) detected more evolving non-STEMI cases (61.5% vs. 7.7%).

Therefore, since consideration is given to one assay at a time, extracting the similarity scores for the conformer pairs tested in each AID from the all-by-all similarity score matrices computed and stored in the first part of study is described in Figure 16. Figure 16 Analysis method overview.

The LDR/hybridization flow-through biochip performed the entire assay at a relatively fast processing speed: 6.5 min for on-chip LDR, 10 min for washing, and 2.6 min for fluorescence scanning (total processing time = 19.1 min) and could screen multiple mutations simultaneously for high throughput applications at a level of one mutant sequence in 100 wild-type sequences.

strains to ensure uniformity of the assay at an intraspecific level, as well as with other fungal species to ensure specificity.

(B) A 4-h LDH release assay, at an effector-to-target (E/T) ratio of 20 1, was used to compare cytotoxicity between CART-HER2, mock T, and NT T cells against different GC cells (C) An 8-h LDH release assay, at an E/T ratio of 20 1, was used to compare cytotoxicity between CART-HER2, mock T, and NT T cells against different GC cells.

A similar result was obtained with the qPCR assay at an earlier time point of 24 h.

This HSV viral replication led to a strong tumour cytotoxcity effect, which was detected by MTS assay at an MOI as low as 0.001 (data not shown).

Future work is in progress to address the major challenge to automate the DNA extraction and PCR assay at an affordable price.